Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Athanasios Alexiou

Showing results (141-150 of 299) with videos related to

Pageof 30
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 17, 2022
Bioactive compounds, pharmacological actions and pharmacokinetics of Cupressus sempervirensGaber El-Saber Batiha, John Oluwafemi Teibo, Hazem M Shaheen, et al.
Research in Veterinary Science|July 2, 2025
Moniezia benedeni infected Zaraibi (Egyptian Nubian) goats: Insights into serum biochemical changes, redox imbalance, and molecular mechanisms of oxidative-inflammatory cascades mediated intestinal injuryMahmoud Abdelhamid, Ahmed Magdy Selim, Ragab Hassan Mohamed, et al.
Metabolic Brain Disease|June 11, 2025
Tirzepatide: a novel therapeutic approach for Alzheimer's diseaseGhadah H Alshehri, Hayder M Al-Kuraishy, Huda Jaber Waheed, et al.
Acta Diabetologica|October 7, 2025
Therapeutic potential of copper II oxide in treating diabetic wounds: an emerging approach for enhanced healingSubhasri Bogadi, Md Ekhtiar Uddin, Veera Venkata Satyanarayana Reddy Karri, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2025
Alzheimer disease: Amyloid peptide controversies and challenges of anti-Aβ immunotherapyNajlaa Hamed Almohmadi, Hayder M Al-Kuraishy, Ali K Albuhadily, et al.
Brain and Behavior|August 12, 2025
Differential Roles of Angiotensin A and Alamandine in Parkinson's Disease: A Therapeutic Perspective on Nonclassical RAS PathwaysGhadah H Alshehri, Hayder M Al-Kuraishy, Ali K Albuhadily, et al.
Pharmacology Research & Perspectives|February 22, 2023
Pros and cons for statins use and risk of Parkinson's disease: An updated perspectiveHayder M Al-Kuraishy, Ali I Al-Gareeb, Athanasios Alexiou, et al.
Cellular and Molecular Neurobiology|December 11, 2024
Exploring the Neuroprotective Effects of Rufinamide in a Streptozotocin-Induced Dementia ModelDarshpreet Kaur, Amarjot Kaur Grewal, Dalia Fouad, et al.
Acta Neurologica Belgica|February 28, 2025
Editorial Expression of Concern to: The probable role of tissue plasminogen activator/neuroserpin axis in Alzheimer's disease: a new perspectiveNaif H Ali, Hayder M Al-Kuraishy, Ali I Al-Gareeb, et al.
Immunity, Inflammation and Disease|November 29, 2023
New insights on the potential effect of progesterone in Covid-19: Anti-inflammatory and immunosuppressive effectsHayder M Al-Kuraishy, Thabat J Al-Maiahy, Ali I Al-Gareeb, et al.
Pageof 30

Showing results (141-150 of 299) with videos related to

Sort By:
Pageof 30
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 17, 2022
Bioactive compounds, pharmacological actions and pharmacokinetics of Cupressus sempervirensGaber El-Saber Batiha, John Oluwafemi Teibo, Hazem M Shaheen, et al.
Research in Veterinary Science|July 2, 2025
Moniezia benedeni infected Zaraibi (Egyptian Nubian) goats: Insights into serum biochemical changes, redox imbalance, and molecular mechanisms of oxidative-inflammatory cascades mediated intestinal injuryMahmoud Abdelhamid, Ahmed Magdy Selim, Ragab Hassan Mohamed, et al.
Metabolic Brain Disease|June 11, 2025
Tirzepatide: a novel therapeutic approach for Alzheimer's diseaseGhadah H Alshehri, Hayder M Al-Kuraishy, Huda Jaber Waheed, et al.
Acta Diabetologica|October 7, 2025
Therapeutic potential of copper II oxide in treating diabetic wounds: an emerging approach for enhanced healingSubhasri Bogadi, Md Ekhtiar Uddin, Veera Venkata Satyanarayana Reddy Karri, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2025
Alzheimer disease: Amyloid peptide controversies and challenges of anti-Aβ immunotherapyNajlaa Hamed Almohmadi, Hayder M Al-Kuraishy, Ali K Albuhadily, et al.
Brain and Behavior|August 12, 2025
Differential Roles of Angiotensin A and Alamandine in Parkinson's Disease: A Therapeutic Perspective on Nonclassical RAS PathwaysGhadah H Alshehri, Hayder M Al-Kuraishy, Ali K Albuhadily, et al.
Pharmacology Research & Perspectives|February 22, 2023
Pros and cons for statins use and risk of Parkinson's disease: An updated perspectiveHayder M Al-Kuraishy, Ali I Al-Gareeb, Athanasios Alexiou, et al.
Cellular and Molecular Neurobiology|December 11, 2024
Exploring the Neuroprotective Effects of Rufinamide in a Streptozotocin-Induced Dementia ModelDarshpreet Kaur, Amarjot Kaur Grewal, Dalia Fouad, et al.
Acta Neurologica Belgica|February 28, 2025
Editorial Expression of Concern to: The probable role of tissue plasminogen activator/neuroserpin axis in Alzheimer's disease: a new perspectiveNaif H Ali, Hayder M Al-Kuraishy, Ali I Al-Gareeb, et al.
Immunity, Inflammation and Disease|November 29, 2023
New insights on the potential effect of progesterone in Covid-19: Anti-inflammatory and immunosuppressive effectsHayder M Al-Kuraishy, Thabat J Al-Maiahy, Ali I Al-Gareeb, et al.
Pageof 30